Picture of Sugentech logo

253840 Sugentech Share Price

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Momentum

Relative Strength (%)
1m+16.37%
3m-2.28%
6m-9.16%
1yr-4.97%
Volume Change (%)
10d/3m+235.72%
Price vs... (%)
52w High-27.59%
50d MA+20.71%
200d MA+13.82%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-20.88%
Return on Equity-13.63%
Operating Margin-336.77%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total RevenueKR₩m3,845.0841,351.8577,201.04101,399.267,132.31n/an/a5.53%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/an/an/a-31.42n/an/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Sugentech EPS forecast chart

Profile Summary

Sugentech Incorporate is a Korea-based company mainly engaged in the production and sale of in-vitro diagnostic test reagents. The Company is involved in the manufacturing and sale of in vitro diagnostic test reagents, point-of-care testing (POCT) products, folic acid products under the name of SOLGAR, as well as molecular diagnostic reagents. The in vitro diagnostic test reagents are for personal use and are sold under the name SUREARLY. The POCT products are for professional use and are sold under the name INCLIX. In addition, the Company is engaged in therapeutic drug monitoring, as well as drug analysis method development. The Company distributes its products within the domestic market and to overseas markets, including Indonesia.

Directors

    Last Annual
    December 31st, 2023
    Last Interim
    December 31st, 2023
    Incorporated
    December 9th, 2011
    Public Since
    November 11th, 2016
    Sector
    Healthcare Equipment & Supplies
    Industry
    Healthcare
    Exchange
    kr flag iconKorea Exchange - KOSDAQ
    Shares in Issue
    16,722,608
    Blurred out image of a map
    Address
    2F, DAEJEON, 34028
    Web
    https://www.sugentech.com/
    Phone
    +82 423645001
    Auditors
    Hanwool Accounting

    253840 Share Price Performance

    Upcoming Events for 253840

    Similar to 253840

    Picture of Access Bio logo

    Access Bio

    kr flag iconKorea Exchange - KOSDAQ

    Picture of Aligned Genetics logo

    Aligned Genetics

    kr flag iconKorea Exchange - KOSDAQ

    Picture of Asta Co logo

    Asta Co

    kr flag iconKorea Exchange - KOSDAQ

    Picture of Biodyne Co logo

    Biodyne Co

    kr flag iconKorea Exchange - KOSDAQ

    Picture of Bistos Co logo

    Bistos Co

    kr flag iconKorea Exchange - KOSDAQ

    FAQ